Email Contact Phone Company Visit Website

Location Office

Kungsgatan 36
Stockholm
SE

NASDAQ OMX New York Head Office

One Liberty Plaza
New York
NY
US

NASDAQ OMX Stockholm Office

Tullvaktsvägen 15
Stockholm
SE

NASDAQ OMX Rockville Office

805 King Farm Boulevard 1st and 2nd floor
Rockville
MD
US

NASDAQ OMX London Office

Woolgate Exchange, 25 Basinghall Street, City of London
London
GB

NASDAQ OMX New York Office

Marketsite 4 Times Square
New York
NY
US

NASDAQ OMX Hong Kong Office

Room 1207-8, 12/F Man Yee Building 68 Des Voeux Road Central Hong Kong
Hong Kong
HK

NASDAQ OMX Singapore Office

20 Collyer Quay, #17-01
Singapore
SG

NASDAQ OMX Chicago Office

One North Wacker Drive Suite 3600
Chicago
IL
US

NASDAQ OMX Belgium Office

Avenue de Cortenbergh 116
Brussels
BE

NASDAQ OMX Dubai Office

Dubai World Trade Centre Sheikh Zayed Road
Dubai
AE

NASDAQ OMX Tokyo Office

1F, Kojimachi Square Building Nibancho, 3 Chiyoda-ku, Tokyo
Tokyo
JP

NASDAQ OMX Boston Office

100 Franklin St
Boston
MA
US

Location Office

Level 17-19, 110 Bishopsgate
London
GB

Telephone

212 231 5018

Contact

Todd A Swearingen
[email protected]
Back to all NASDAQ OMX announcements

Nasdaq Welcomes VWR Corporation (Nasdaq: VWR) to The Nasdaq Stock Market

The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) announced that VWR Corporation (Nasdaq:VWR), a leading, independent provider of laboratory products, services and solutions, commenced trading on The Nasdaq Stock Market on October 2, 2014.

VWR enables science in laboratory and production facilities in the pharmaceutical, biotechnology, industrial, education, government and healthcare industries. With more than 160 years of experience, VWR offers a well-established network that reaches thousands of specialized laboratories and facilities spanning the globe. VWR has more than 8,500 associates working to streamline the way scientists, medical professionals and production engineers stock and manage their businesses. In addition, VWR supports its customers by providing value-added service offerings, research support, laboratory services and operations services.

"VWR's industry-leading portfolio of over 3 million branded, private label and internally manufactured products supports their 120,000 worldwide customers to enable science every day," said Nelson Griggs, Senior Vice President, Corporate Client Group, Nasdaq. "We look forward to celebrating many more milestones with VWR in the future and we congratulate them on their successful initial public offering."

By listing with Nasdaq, VWR joins some of the world's largest and most revolutionary healthcare companies. Nasdaq has been the exchange of choice to 93 percent of healthcare companies that have listed on the U.S. markets year-to-date in 2014.